
中东和非洲 miRNA 测序和检测市场预测至 2027 年 - COVID-19 影响和按产品(文库制备和耗材)、技术(合成测序、纳米孔和离子半导体测序)和最终用户(研究所、学术界和 CRO)
No. of Pages: 121 | Report Code: TIPRE00022149 | Category: Life Sciences
No. of Pages: 121 | Report Code: TIPRE00022149 | Category: Life Sciences
miRNA是一种20-30个核苷酸的小非编码RNA分子,在基因调控中发挥着重要作用。 miRNA 与信使 RNA (mRNA) 部分互补,其主要功能是下调基因表达。自从它们被发现以来,它们已成为重要细胞功能的重要调节者。 miRNA 与病毒感染、自身免疫性疾病和癌变等病理过程相关。
miRNA 参与分化过程;它们作为识别细胞类型的有用标记发挥着至关重要的作用。 miRNA 与病毒感染、自身免疫性疾病和癌变等病理过程相关。因此,人们正在进行广泛的研究来鉴定新的 miRNA。此外,关于 miRNA 在疾病发展中的作用的发现使 miRNA 成为新型治疗方法的关键目标。几种针对癌症和肝炎等疾病的 miRNA 靶向疗法已进入临床阶段。例如,Santaris Pharma 开发了一种名为 Miravirsen 的治疗分子,靶向 miR-122,用于治疗丙型肝炎病毒(HCV)感染;该分子正处于 II 期临床试验中。因此,miRNA 应用范围的不断扩大正在推动 miRNA 测序和检测市场的增长。同样,中东和非洲地区用于识别新分子来诊断和治疗疾病的基因组研究资金的增加正在推动市场增长。
中东地区的国家正在正在经历 COVID-19 大流行的严重影响。各国封锁的初期影响了这些地区许多仪器和消耗品的供应。由于 COVID-19 病例激增,中东地区对新型诊断测试的需求不断增加,研究活动导致该地区更多地采用 miRNA 测序和检测程序。因此,持续的疫情对中东和非洲的 miRNA 测序和检测市场产生了积极影响。
主要细分市场
中东和非洲 miRNA 测序和检测市场按产品细分为文库制备和耗材。耗材细分市场在 2019 年占据了更大的市场份额,而文库制备细分市场预计在预测期内将实现更高的复合年增长率。
基于技术中东和非洲 miRNA 测序和检测市场分为合成测序、纳米孔测序和离子半导体测序。合成测序领域在 2019 年占据了最大的市场份额;然而,纳米孔细分市场预计在 2020 年至 2027 年期间将实现最高的复合年增长率。
根据最终用户,中东和非洲 miRNA 测序和检测市场分为研究机构、学术界和 CRO。研究机构细分市场在 2019 年占据了最大的市场份额,预计在此期间的市场复合年增长率最高。
span>
Strategic insights for Middle East and Africa miRNA Sequencing and Assay involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Report Attribute | Details |
---|---|
Market size in 2019 | US$ 8.71 Million |
Market Size by 2027 | US$ 22.00 Million |
Global CAGR (2020 - 2027) | 12.4% |
Historical Data | 2017-2018 |
Forecast period | 2020-2027 |
Segments Covered |
By 产品
|
Regions and Countries Covered | 中东和非洲
|
Market leaders and key company profiles |
The regional scope of Middle East and Africa miRNA Sequencing and Assay refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The List of Companies - Middle East and Africa miRNA Sequencing and Assay Market
The Middle East and Africa miRNA Sequencing and Assay Market is valued at US$ 8.71 Million in 2019, it is projected to reach US$ 22.00 Million by 2027.
As per our report Middle East and Africa miRNA Sequencing and Assay Market, the market size is valued at US$ 8.71 Million in 2019, projecting it to reach US$ 22.00 Million by 2027. This translates to a CAGR of approximately 12.4% during the forecast period.
The Middle East and Africa miRNA Sequencing and Assay Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Middle East and Africa miRNA Sequencing and Assay Market report:
The Middle East and Africa miRNA Sequencing and Assay Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Middle East and Africa miRNA Sequencing and Assay Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Middle East and Africa miRNA Sequencing and Assay Market value chain can benefit from the information contained in a comprehensive market report.